The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy.

OBJECTIVES To characterize nonprescription nicotine replacement therapy (NRT) users with respect to sociodemographic characteristics, tobacco use history, and support for tobacco cessation received from health care professionals; assess the methods used for quitting (past and present) by NRT users; assess NRT users' perceptions of the need for and usefulness of pharmacist-facilitated cessation interventions; and determine the types of pharmacy-based interventions that would be most helpful before and during quit attempts. DESIGN One-time attitudinal assessment. SETTING Primarily Northern California. PARTICIPANTS One hundred three individuals who had recently purchased nonprescription NRT products for use during their current or upcoming quit attempt. INTERVENTION In-depth telephone interviews. MAIN OUTCOME MEASURE Perceptions of pharmacy-based tobacco cessation counseling services. RESULTS The concept of pharmacist-facilitated assistance was appealing to many NRT users. Sixty-three percent of participants believed that receiving advice or assistance from a pharmacist would either probably (46%) or definitely (17%) increase a smoker's likelihood of being able to quit. Twenty-one percent were unsure, and 16% thought pharmacist assistance would not increase the chance of success. Forty-six percent reported that they would be either very or extremely likely to meet with a pharmacist for one-on-one counseling if a nominal ($10) co-payment were required; this percentage increased to 68% if the service were provided free of charge. The preferred structure for counseling interventions varied widely among participants, suggesting that individually tailored counseling programs are necessary. CONCLUSION A substantial proportion of nonprescription NRT users view pharmacist-assisted cessation as an appealing approach to smoking cessation.

[1]  A. Prokhorov,et al.  Development and implementation of a tobacco cessation training program for students in the health professions. , 2003, Journal of cancer education : the official journal of the American Association for Cancer Education.

[2]  E. Gilpin,et al.  Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. , 2002, JAMA.

[3]  T. Hu,et al.  The benefits of switching smoking cessation drugs to over-the-counter status. , 2002, Health economics.

[4]  M. Ryan,et al.  Effectiveness of a Pharmacist‐Based Smoking‐Cessation Program and Its Impact on Quality of Life , 2002, Pharmacotherapy.

[5]  A. Segal,et al.  Patients' views of pharmacists as providers of smoking cessation services. , 2002, Journal of the American Pharmaceutical Association.

[6]  A. Mcalister,et al.  Smoking cessation activities by pharmacists in East Texas. , 2002, Journal of the American Pharmaceutical Association.

[7]  Stephen J. Hellebusch,et al.  Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. , 2002, Addiction.

[8]  N. Rigotti,et al.  Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. , 2002, American journal of public health.

[9]  M. Doescher,et al.  Pilot study of enhanced tobacco-cessation services coverage for low-income smokers. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[10]  D. T. Kennedy,et al.  Development and implementation of a smoking cessation clinic in community pharmacy practice. , 2002, Journal of the American Pharmaceutical Association.

[11]  R. E. Small,et al.  Results of a smoking cessation clinic in community pharmacy practice. , 2002, Journal of the American Pharmaceutical Association.

[12]  Mary T. Roth,et al.  Use of Bupropion SR in a Pharmacist‐Managed Outpatient Smoking‐Cessation Program , 2001, Pharmacotherapy.

[13]  D. M. Barbour Development and implementation of a tobacco consultation program for managed care pharmacists. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  M. Lahoz,et al.  Smoking cessation activities in South Carolina community pharmacies. , 2000, Journal of the American Pharmaceutical Association.

[15]  S. Shiffman,et al.  Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998. , 2000, MMWR. Morbidity and mortality weekly report.

[16]  T. Brock,et al.  An evaluation of smoking cessation-related activities by pharmacists. , 2000, Journal of the American Pharmaceutical Association.

[17]  Mc Fiore,et al.  Treating Tobacco Use and Dependence , 2000 .

[18]  D. Schroeder,et al.  Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. , 1999, American journal of public health.

[19]  R. West,et al.  Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. , 1999, Archives of internal medicine.

[20]  M. Fiore,et al.  Does over-the-counter nicotine replacement therapy improve smokers’ life expectancy? , 1998, Tobacco control.

[21]  P. Donnan,et al.  Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland , 1998, Tobacco control.

[22]  D. Ferry,et al.  Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies , 1998, Tobacco control.

[23]  S. Shiffman,et al.  Public health benefit of over-the-counter nicotine medications. , 1997, Tobacco control.

[24]  K. Overvad,et al.  Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. , 1997, American journal of epidemiology.

[25]  G. Oster,et al.  The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum"). , 1996, Medical care.

[26]  M. Smith,et al.  Pharmacist counseling and outcomes of smoking cessation. , 1995, American pharmacy.

[27]  W. Baluch Pharmacists' role in a smoking-cessation program at a health maintenance organization. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[28]  N. L. Lee,et al.  Pharmacists' role in a smoking-cessation program at a managed health care organization. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[29]  B. Rimer,et al.  Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. , 1994, JAMA.

[30]  P. Hauri,et al.  Serum nicotine and cotinine levels during nicotine‐patch therapy , 1993, Clinical pharmacology and therapeutics.

[31]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.